Corrigendum: Cost-effectiveness of avelumab maintenance therapy plus best supportive care vs. best supportive care alone for advanced or metastatic urothelial carcinoma

Bibliographic Details
Main Authors:	Qian Xie, Hanrui Zheng, Ye Chen, Xingchen Peng
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-07-01
Series:	Frontiers in Public Health
Subjects:	programmed cell death ligand 1 avelumab cost-effective advanced or metastatic urothelial cancer maintenance therapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fpubh.2022.965798/full

Internet